Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 6/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.37 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.37 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.37 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.37 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43173 | 1.00 | HPGD (0.42) | HPGDHDAC1HDAC2HDAC3HDAC4 | |
| SCHEMBL31005444 | 1.00 | HPGD (0.42) | HPGDHDAC1HDAC2HDAC3HDAC4 | |
| SCHEMBL14273419 | 0.96 | HPGD (0.43) | HPGDHDAC1HDAC2ALDH1A1SMN1; SMN2 | |
| SCHEMBL31005443 | 0.96 | HPGD (0.43) | HPGDHDAC1HDAC2ALDH1A1SMN1; SMN2 | |
| SCHEMBL29201024 | 0.94 | HPGD (0.39) | HPGDHDAC1HDAC2HDAC3HDAC4 | |
| SCHEMBL18510191 | 0.92 | HPGD (0.45) | HPGDHDAC1HDAC2ALDH1A1SMN1; SMN2 | |
| SCHEMBL18510177 | 0.92 | HPGD (0.45) | HPGDHDAC1HDAC2ALDH1A1SMN1; SMN2 | |
| SCHEMBL18519268 | 0.92 | HPGD (0.45) | HPGDHDAC1HDAC2ALDH1A1SMN1; SMN2 | |
| SCHEMBL18510194 | 0.91 | HPGD (0.44) | HPGDHDAC1HDAC2ALDH1A1SMN1; SMN2 | |
| SCHEMBL18510196 | 0.91 | HPGD (0.44) | HPGDHDAC1HDAC2ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719485-A1 | ANTIBODY-DRUG CONJUGATES FOR TREATING INFECTIONS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) | Taimed Biologics Inc. (TW) | 2026-04-08 | — | — | EP | claimed |
| EP-4716755-A1 | RNA PROBING AND AMPLIFICATION METHODS FOR SINGLE CELL ANALYSIS ON FIXED CELLS | Becton, Dickinson and Company (US) | 2026-04-01 | — | — | EP | claimed |
| US-12578320-B2 | Methods and systems for physical expansion and imaging of biological samples | YALE UNIVERSITY (US) | 2026-03-17 | — | — | US | claimed |
| WO-2025235971-A1 | METHODS FOR DETECTING DNA SEQUENCE VARIATION IN THICK TISSUE SECTIONS | THE JOHNS HOPKINS UNIVERSITY (US) | 2025-11-13 | — | — | WO | claimed |
| EP-4642491-A1 | METHOD FOR GLYCOPROTEIN MODIFICATION | Honeybear Biosciences Inc. (TW) | 2025-11-05 | — | — | EP | claimed |
| US-20250295745-A1 | CROSS-LINKED TUMOR LYSATE SPHERICAL NUCLEIC ACIDS AS CANCER VACCINES | NORTHWESTERN UNIVERSITY | 2025-09-25 | — | — | US | claimed |
| EP-4615969-A1 | METHODS FOR DETECTING RNA AND MOLECULAR ANALYSIS IN THICK TISSUE SECTIONS | The Johns Hopkins University (US) | 2025-09-17 | — | — | EP | claimed |
| US-12330138-B2 | Surface functionalised materials for sampling biological molecules | JONES, Paul Antonio (GB) | 2025-06-17 | — | — | US | claimed |
| EP-3765188-B1 | SURFACE FUNCTIONALISED MATERIALS FOR SAMPLING BIOLOGICAL MOLECULES | JONES PAUL ANTONIO (GB) | 2025-04-16 | — | — | EP | claimed |
| CN-112533640-B | Targeting of M2-type tumor-associated macrophages using melittin-based apoptosis-inducing peptides | 双亥生命科学株式会社 | 2025-02-28 | — | — | CN | claimed |
| EP-4117820-A1 | METHODS AND SYSTEMS FOR PHYSICAL EXPANSION AND IMAGING OF BIOLOGICAL SAMPLES | Yale University (US) | 2023-01-18 | — | — | EP | claimed |
| CN-115551638-A | Method and system for physical expansion and imaging of biological samples | 耶鲁大学 | 2022-12-30 | — | — | CN | claimed |
| EP-4103744-A2 | INTRACELLULAR ABSEQ | Becton, Dickinson and Company (US) | 2022-12-21 | — | — | EP | claimed |
| EP-4103585-A1 | PEPTIDES TARGETING MACROPHAGES, AND CONJUGATES, COMPOSITIONS, AND USES THEREOF | Twinpig Biolab, Inc. (KR) | 2022-12-21 | — | — | EP | claimed |
| US-20220354957-A1 | PEPTIDES TARGETING MACROPHAGES, AND CONJUGATES, COMPOSITIONS, AND USES THEREOF | TWINPIG BIOLAB, INC. (KR) | 2022-11-10 | — | — | US | claimed |
| WO-2022234346-A1 | PEPTIDES TARGETING MACROPHAGES, AND CONJUGATES, COMPOSITIONS, AND USES THEREOF | TWINPIG BIOLAB, INC. (KR) | 2022-11-10 | — | — | WO | claimed |
| US-11484601-B2 | Targeting M2-like tumor-associated macrophages by using melittin-based proapoptotic peptide | TWINPIGBIOLAB INC. (KR) | 2022-11-01 | — | — | US | claimed |
| CN-115087746-A | Intracellular AbSeq | 贝克顿迪金森公司 | 2022-09-20 | — | — | CN | claimed |
| WO-2022129926-A1 | IMPROVED CELL-PENETRATING PEPTIDES AND FUSION PROTEINS | ANASTASIS BIOTEC LIMITED (GB) | 2022-06-23 | — | — | WO | claimed |
| US-11332880-B2 | Modifying natural feathers for use in sporting goods | DURABIRD (US) | 2022-05-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12578320-B2 | Methods and systems for physical expansion and imaging of biological samples | KRT18, DSP, SMCHD1 | HPGD 4825/4885HDAC1 2380/4885HDAC2 3179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.